<DOC>
	<DOCNO>NCT02217332</DOCNO>
	<brief_summary>Phase 2 , open-label , multi-center study evaluate clinical effect oral administration dexpramipexole 6 month subject chronic sinusitis nasal polyp eosinophilia .</brief_summary>
	<brief_title>Study Dexpramipexole Chronic Sinusitis With Nasal Polyps Eosinophilia</brief_title>
	<detailed_description>This open-labelled study evaluate safety preliminary efficacy dexpramipexole reduce number eosinophil peripheral blood improve nasal polyp score administer 20 subject chronic sinusitis nasal polyp eosinophilia . Subjects receive dexpramipexole 6 month safety test perform monthly efficacy evaluation perform month 1 , month 3 , month 6 begin study drug .</detailed_description>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Eosinophilia</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Male female &gt; 18 &lt; 70 year age Willing practice effective contraception study willing able continue contraception 1 month ( female ) 3 month ( male ) last dose study treatment Confirmed diagnosis chronic sinusitis nasal polyp Documented history nasal eosinophilia Documented peripheral absolute eosinophil count &gt; 300 cells/μL Bilateral total polyp score &gt; 4 Sinonasal outcome test ( SNOT22 ) score &gt; 7 Using intranasal corticosteroid spray irrigation ( &lt; 1000 μg/day beclomethasone equivalent ) Acute sinusitis , concurrent nasal infection , subject nasal upper respiratory tract infection within 2 week prior baseline CT scan suggestive allergic fungal rhinosinusitis Nasal septal deviation would occlude least one nostril Nasal surgery ( include polypectomy ) within 6 month prior baseline History 5 sinonasal surgery require general anesthesia History 2 sinonasal surgery change lateral wall nose History cystic fibrosis , primary ciliary 's dysfunction Kartagener 's syndrome History diagnosis parasitic infection Hospitalization emergency treatment treatment asthma two time 12 month prior baseline Hospitalization acute asthmatic attack within 4 week prior baseline Forced expiratory volume ( FEV1 ) &lt; 60 % predict normal range Treatment systemic corticosteroid intrapolyp corticosteroid within 8 week prior baseline anticipate need systemic corticosteroid study treatment period Utilization rescue oral corticosteroid asthma chronic sinusitis exacerbation one time within past 1 year Treatment investigational drug previous 30 day 5halflives , whichever longer Treatment monoclonal antibody therapy include omalizumab ( Xolair® ) , within 5halflives Treatment zileuton ( Zyflo® ) within 4 week baseline Treatment pramipexole ( Mirapex® ) within 4 week baseline History malignancy , include solid tumor hematologic malignancy ( except basal cell squamous cell cancer skin completely excise cure ) History human immunodeficiency virus ( HIV ) hepatitis B C History unstable severe cardiac , hepatic , renal disease , medically significant illness Medical condition likely interfere subject 's ability undergo study procedure , adhere visit schedule comply study requirement Absolute neutrophil count &lt; 2000 cells/μL screening , document history neutropenia Total IgE &gt; 1500 IU/ml visit prior baseline Renal dysfunction , define estimate glomerular filtration rate ( eGFR ) ≤80 mg/dL screening ( estimation creatinine clearance use MDRD formula ) History long QT syndrome arrhythmia Prolongation QT/QTc interval ( e.g. , repeated demonstration QT/QTc interval &gt; 450 m ) screen predose day 1 Clinically important abnormality rest ECG may interfere interpretation QTc interval change screen predose day 1 , include follow : PR interval &gt; 210 m ; QRS &gt; 110 m ; Heart rate &lt; 45 bpm &gt; 100 bpm ( average 3 assessment ) . Pregnant woman woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Sinusitis</keyword>
	<keyword>Rhinosinusitis</keyword>
	<keyword>CRS</keyword>
	<keyword>CRSwNP</keyword>
	<keyword>CSNP-E</keyword>
	<keyword>Nasal polyp</keyword>
	<keyword>Nasal polyposis</keyword>
	<keyword>Eosinophilia</keyword>
	<keyword>Asthma</keyword>
</DOC>